| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 70,504 | 80,163 | 119,340 | 241,097 | | Cost of Revenue | 46,315 | 96,001 | 97,688 | 211,209 | | | Gross Profit | 24,189 | (15,838) | 21,652 | 29,888 | | | Operating Expenses | | Research Development | 14,246 | 16,229 | 21,508 | 26,634 | | Selling General and Administrative | 33,139 | 26,971 | 54,180 | 46,360 | | Non Recurring | 10,266 | 26,400 | 4,819 | 35,952 | | Others |
-
|
-
|
-
| 278 | | | | Total Operating Expenses |
-
|
-
|
-
| 109,224 | | | | Operating Income or Loss | (33,794) | (85,438) | (58,855) | (79,336) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,426) | 6,028 | (6,465) | (1,439) | | Earnings Before Interest And Taxes | (34,888) | (79,410) | (65,320) | (80,775) | | Interest Expense | 24 | 230 | 290 | 465 | | Income Before Tax | (34,912) | (79,640) | (65,610) | (81,240) | | Income Tax Expense | (317) | 4,659 | 1,824 | (309) | | Minority Interest | 32 |
-
|
-
| (18) | | | | Net Income From Continuing Ops | (34,563) | (84,299) | (67,434) | (80,949) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (34,563) | (84,299) | (67,434) | (80,949) | | Preferred Stock And Other Adjustments | (17) | 16 | 1 |
-
| | | Net Income Applicable To Common Shares | ($34,580) | ($84,283) | ($67,433) | ($80,949) |
|
0.31% Nasdaq 0.00%
Income Statement
